NewAmsterdam Pharma Co N.V.

NAMS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $3.3B · 100 employees
90
SEC Filings
$27.67
Close 2026-08-06
100
Employees

Business Summary

PART I Overview We are a late-stage biopharmaceutical company whose mission is to improve patient care in populations with cardiometabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well tolerated and convenient low-density lipoprotein cholesterol (LDL-C) lowering therapy. In multiple Phase 3 trials, we have investigated obicetrapib, an oral, low-dose, once-daily, highly selective cholesteryl ester tr...

Latest Stock Quote

NAMS 2026-08-06 $27.67 O:$27.63 H:$27.98 L:$27.3 Vol:1.6M VWAP:$27.6157
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-182025-12-310001193125-26-056029EDGAR133K words
2025-02-262024-12-310000950170-25-027339EDGAR—
2024-02-282023-12-310000950170-24-021668EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300001193125-26-333824EDGAR—
2025-11-052025-09-300001193125-25-265796EDGAR24K words
2025-08-062025-06-300000950170-25-103521EDGAR—
2025-05-082025-03-310000950170-25-066413EDGAR—
2024-11-062024-09-300000950170-24-121828EDGAR—
2024-08-072024-06-300000950170-24-092281EDGAR—
2024-05-082024-03-310000950170-24-055767EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-050001193125-26-333827EDGAR—
2026-07-240001193125-26-315163EDGAR—
2026-07-220001193125-26-312390EDGAR—
2026-03-020001193125-26-084266EDGAR1K words
2026-02-180001193125-26-056020EDGAR—
2026-01-090001193125-26-008300EDGAR—
2025-11-050001193125-25-265800EDGAR—
2025-09-020000950170-25-112345EDGAR—
2025-08-180000950170-25-109567EDGAR—
2025-08-150000950170-25-109387EDGAR—

90 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Company Identity

CIK0001936258
TickerNAMS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedP7
Websitehttps://www.newamsterdampharma.com
Listed2022-11-23

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8142101a62bc7daa7dd8d8336dabd9a162d9ab8cf48669f2c1f8226638adcf95
parent: 01c749a1f857eb8b8ae10bcf3df3b98a0cc193a12a5f1635489f9aa1f7ac8c66
content hash: bdf16817f900a6e45fc57273ab16768cbafa9e148e328816e16782ec43893f95
signed: 2026-08-11T12:04:32.731Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NAMS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NAMS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NAMS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.